Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01278290|
Recruitment Status : Unknown
Verified December 2010 by Hospital de Niños R. Gutierrez de Buenos Aires.
Recruitment status was: Active, not recruiting
First Posted : January 17, 2011
Last Update Posted : January 17, 2011
The aim of the study is to determine the specificity, sensitivity and diagnostic efficiency of the Triptorelin Test in the assessment of CPP compared to GnRH test as gold standard.
Hypothesis: Aqueous Triptorelin Acetate is so efficient as GnRH to CPP assessment.
Study population are girls with suspicious clinical features of precocious puberty
|Condition or disease||Intervention/treatment||Phase|
|Central Precocious Puberty Sexual Precocity||Drug: Triptorelin acetate and Gonadorelin acetate Drug: Gonadorelin acetate and Triptorelin acetate||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Triptorelin Acetate Utilization for the Early Diagnosis of Central Precocious Puberty (CPP) in Girls.|
|Study Start Date :||July 2010|
|Estimated Primary Completion Date :||April 2011|
|Estimated Study Completion Date :||October 2011|
Active Comparator: Triptorelin test AND LHRH test
Patients undergo two tests with a test interval of at least 15 days
Drug: Triptorelin acetate and Gonadorelin acetate
Triptorelin acetate aqueous 0.1 mg/m2 subcutaneous. Gonadorelin acetate 100 ug intravenous.
Active Comparator: LHRH test AND Triptorelin test
Patients undergo two test with a test interval of al least 15 days.
Drug: Gonadorelin acetate and Triptorelin acetate
Gonadorelin acetate intravenous 100 ug. Triptorelin acetate 100 ug/m2.
- LH [ Time Frame: 3 hs ]Levels of LH are measured at T 0 (before) and T 3 h y T 24 h (after) Triptorelin stimulation.
- Estradiol [ Time Frame: 24 hs ]Levels of Estradiol are measured at T 0 (before) and T 3 h y T 24 h (after) Triptorelin stimulation.
- FSH [ Time Frame: 3 hs ]Levels of FSH are measured at T 0 (before) and T 3 h y T 24 h (after) Triptorelin stimulation.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01278290
|Hospital de Niños Ricardo Gutierrez, División de Endocrinología|
|Ciudad Autónoma de Buenos Aires, Argentina, C1425SEFD|
|Study Director:||Maria G Ropelato, PhD||División de Endocrinología, Hospital de Niños Ricardo Gutierrez, Buenos Aires, Argentina|
|Principal Investigator:||Analía V Freire, MD||División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina|